Zdrowie i gospodarka · 26/03/1998

FDA Corrects Expedited Safety Reporting Requirements for Human Drug and Biological Products

The Food and Drug Administration (FDA) is revising a rule to ensure the accuracy and consistency of expedited safety reporting regulations for human drug and biological products, which were previously published in the Federal Register on October 7, 1997.